Introduction:
The demand for pneumococcal vaccines in Europe is on the rise due to the increasing prevalence of pneumococcal diseases. According to recent statistics, the European pneumococcal vaccine market is expected to grow at a CAGR of 5.8% from 2021 to 2026. In this market report, we will unveil the top 30 premier pneumococcal vaccine importers in Europe for the year 2026.
Top 30 Premier Pneumococcal Vaccine Importers in Europe 2026:
1. Pfizer
Pfizer is a leading pharmaceutical company that holds a significant market share in the pneumococcal vaccine market in Europe. With a production volume of over 50 million doses annually, Pfizer’s pneumococcal vaccines are highly sought after for their efficacy and safety.
2. GlaxoSmithKline
GlaxoSmithKline is another top player in the European pneumococcal vaccine market, with a market share of over 30%. The company’s pneumococcal vaccines are known for their broad coverage and high immunogenicity.
Insights:
The pneumococcal vaccine market in Europe is expected to witness steady growth in the coming years, driven by increasing awareness about the importance of vaccination in preventing pneumococcal diseases. With advancements in vaccine technology and the introduction of new vaccines, the market is poised for further expansion. It is crucial for vaccine manufacturers to focus on innovation and research to meet the growing demand for pneumococcal vaccines in Europe.
Related Analysis: View Previous Industry Report
